Condition: LARS - Low Anterior Resection Syndrome · Rectal Cancer Surgery · Rectal Cancer · Sponsor: University Hospital, Basel, Switzerland
The goal of this clinical study is to gain further insights into the treatment of patients with Low Anterior Resection Syndrome (LARS) symptoms after rectal resection. The main question is: Can LARS symptoms and quality of life be improved by implementing an intensified follow-up program? Researchers will compare the results of the intervention group with the results of a control group in which patients do not receive an intensified follow-up program to determine whether the intervention works. Participants will undergo an intensified follow-up program which consists of several follow-up visits and medical treatment, pelvic floor muscle training and gynaecological and urological co-treatment in case of LARS symptoms and urinary or sexual complaints.
This description comes directly from the study's public registry record.
Felicitas Wiedemann, Resident · +41 61 777 76 09 · felicitasinga.wiedemann@clarunis.ch
Marco von Strauss und Torney, Senior physician · +41 61 777 7581 · marco.vonstrauss@clarunis.ch
Always discuss trial participation with your own doctor first.
| Clarunis Universitäres Bauchzentrum Basel | Basel, Switzerland | Recruiting |
| Lindenhofspital Bern | Bern, Switzerland | Recruiting |
| St. Anna Spital Bern | Bern, Switzerland | Not Yet Recruiting |
| Kantonsspital Luzern | Lucerne, Switzerland | Recruiting |
| Kantonsspital Winterthur | Winterthur, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06936774